REPLY

Luis Calzadilla-Bertot¹, Eduardo Vilar-Gomez^{2

3}, Jacob George⁴, Leon A Adams^{1

5}

Affiliations

¹ Medical School, Faculty of Health and Medical Sciences, the University of Western Australia, Nedlands, Western Australia, Australia.
² Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN.
³ Unit for the Clinical Management of Digestive Diseases. Biomedical Research Networking Center in Hepatic and Digestive Diseases, Virgen del Rocio University Hospital, University of Seville, Seville, Spain.
⁴ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
⁵ Department of Hepatology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Comment

Luis Calzadilla-Bertot et al. Hepatology. 2021 Jul.

. 2021 Jul;74(1):531-532.

doi: 10.1002/hep.31666. Epub 2021 Jun 15.

Luis Calzadilla-Bertot¹, Eduardo Vilar-Gomez^{2

3}, Jacob George⁴, Leon A Adams^{1

5}

¹ Medical School, Faculty of Health and Medical Sciences, the University of Western Australia, Nedlands, Western Australia, Australia.
² Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN.
³ Unit for the Clinical Management of Digestive Diseases. Biomedical Research Networking Center in Hepatic and Digestive Diseases, Virgen del Rocio University Hospital, University of Seville, Seville, Spain.
⁴ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
⁵ Department of Hepatology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

No abstract available

Comment on

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.
Calzadilla-Bertot L, Vilar-Gomez E, Wong VW, Romero-Gomez M, Aller-de la Fuente R, Wong GL, Castellanos M, Eslam M, Desai AP, Jeffrey GP, George J, Chalasani N, Adams LA. Calzadilla-Bertot L, et al. Hepatology. 2021 Jun;73(6):2238-2250. doi: 10.1002/hep.31576. Epub 2021 Apr 19. Hepatology. 2021. PMID: 32978796
Letter to the Editor: ABIDE in NAFLD: A Potential Game Changer in a Select Cohort of Cirrhosis.
Keisham A, Taneja S, Roy A, Singh V. Keisham A, et al. Hepatology. 2021 Jul;74(1):530. doi: 10.1002/hep.31667. Epub 2021 Apr 27. Hepatology. 2021. PMID: 33275770 No abstract available.

1. Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 2018;155:443-457.e17.
1. Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012;98:691-698.
1. Anstee QM, Lawitz EJ, Alkhouri N, Wong VS, Romero-Gomez M, Okanoue T, et al. Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials. Hepatology 2019;70:1521-1530.
1. Calès P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990;98:156-162.
1. Maukonen M, Mannisto S, Tolonen H. A comparison of measured versus self-reported anthropometrics for assessing obesity in adults: a literature review. Scand J Public Health 2018;46:565-579.